Navigation Links
A Chinese herb kills cancer cells

A herb of Chinese origin which is basically used to treat malaria, kills cancer cells too using a similar mechanism. The drug artemisinin is extracted from the wormwood plant. Knowing that artemisinin works by interacting with high iron levels in malaria parasites, researcher Henryi of the University of Texas wondered if the same approach would work with cancer cells. For it's known that cancer cells often have much higher iron concentrations that healthy cells.

Professor Henry and his team pumped up breast cancer //cells with iron and then introduced artemisinin and found that after 10 hours all the cells were dead. With leukaemia cells, which can concentrate up to 1020 times more iron than healthy cells, the results were even more dramatic - death within just eight hours. What is basically needed now is some rigorous animal studies - observations to date suggest that the new drug may be very effective, but more research is needed.


'"/>




Page: 1

Related medicine news :

1. Chinese paracetamol may be slapped with dumping duty
2. Stay young the Chinese way
3. Chinese herbal remedies aids in cancer treatment
4. Prohibited diet medicine found in Chinese herbs
5. Global Outbreak Of Bird Flu Warning By Chinese Scientist
6. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
7. Unscrupulous Chinese Medicine traders putting lives at risk
8. Chinese City Suspends Water Supply Fearing Pollution
9. Running Water Restored In Chinese City
10. Mass Bird flu vaccination to Chinese Poultry
11. Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Chinese herb kills cancer cells

(Date:9/5/2008)...dy finds sorafenib helps reverse disease resistanc...ept. 5 (HealthDay News) -- The drug sorafenib may ...o anti-hormonal drugs, Georgetown University Medi...en-receptor or progesterone-receptor positive (ER ...ke anti-hormonal medicines, such as aromatase inhi...
(Date:9/5/2008)... New York Fashion Week,s Annual Desti... New York, New York (PRWEB) September 5, 200...r Centers __title__ American Laser], the largest p...e aesthetic services in the U.S., announces sponso... Week. STYLE360, from Sept. 7-10, serves as the a...
(Date:9/4/2008)...3, 2008In a case-control study, the presence of me...h autism and GI disturbances than in children with...d autism onset were unrelated to MMR vaccine timin...lic Library of Science on September 4 ( http://dx...r to the implementation of measles vaccines in 196...
(Date:9/4/2008)...nt stronger labeling about fungal infection risk ...- Federal health authorities have asked the manufa...s to bolster safety warnings on the risk of develo...gs, Humira, Cimzia, Enbrel and Remicade, belong to...ctor alpha blockers (TNF-alpha blockers), which su...
Breaking Medicine News(10 mins):Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3
..., is a common problem among critically ill patient...// The condition can be caused by a number of fact...e metabolism, various medications, or even some nu...have shown hyperglycemia can worsen outcomes for p...
...ents lose the ability to do simple mathematical ca...hers conducted a study to look at the association .... The study included 20 patients with Alzheimer’s ... Alzheimer’s disease and nine were diagnosed with ...
...ble ( RGP ) contact lenses can minimize the chance...hers according to a recent study . More than 100 c...About half the group wore RGP lenses, and the othe...o wore the RGPs generally needed about two weeks t...
... stops the growth of the AIDS virus in the blood m...searchers say alpha-1 antitrypsin (AAT) -- a prote...uses from multiplying. In order for cells to grow,...ay the concept is “...kind of like cutting a compu...
Other Medicine News:
(Date:9/4/2008)...wswire/ -- Southern Research Institute,today annou...has selected,the organization to participate in th...n Center Network (MLPCN). The MLPCN -- a collabora...Libraries Program which is,designed to benefit hum...an,genome and validate future targets for drug dis...
(Date:9/4/2008)...4 /- Axentis Pharma AG has,initiated ...d tolerability,of a new therapeutic formulation fo...ystic fibrosis patients. The new formulation allow... directly to the site of,infection. The forthcomin...rent doses of the new drug. Initial results are ex...
(Date:9/4/2008)... antiviral activity and favorable safety ... Sept. 4 /- Idenix,Pharmace...l company engaged,in the discovery and development...er infectious diseases, today announced that it ha...IDX899, a non-nucleoside reverse,transcriptase inh...
(Date:9/4/2008)...edule with Two Abstracts Accepted for Presenta...2008, BRIDGEWATER, N.J., Sept. 4 /- ...ceutical company focused on the treatment of,cardi...he appointment of,Peter L. Garrambone, Jr. to the ... career includes more than 50 pharmaceutical,trans...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Oncolytics Biotech Inc Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 5470 1Oncolytics Biotech Inc Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 5470 2Tempo Participacoes Announces Increase of 34 25 in EBITDA and of 25 25 in Net Revenue for the 1Q08 19574 1ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 1ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 2ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 3ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 4ADVENTRX Announces ANX 530 Safety Data From Registrational Bioequivalence Clinical Study 2094 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 1Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia Pacific Liver Cancer Study 2093 6
...as--(BUSINESS WIRE)--Jun 11, 2007 - Repros,Therape... findings,from its six month study of Proellex in ...ted in Europe, enrolled 39,premenopausal women and...luded three dose levels of Proellex(TM) as well as...Lucrin(R), a GnRH,agonist also known as Lupron(R) ...
...on of Phase II Study Demonstrates Significant,Addi...NGTON, Mass., June 12, 2007 /PRNewswire-FirstCall/...that results from the,Company,s Phase II EXPRESS t...ttering will be presented today at the 47th annual...(NCDEU), sponsored,by National Institute for Menta...
Other Medicine Technology:Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 2Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 4Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 5Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: